Northwest Investment Counselors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$28.9K Buy
+502
New +$27.1K 0.01% 301
2024
Q2
Sell
-482
Closed -$23.4K 445
2024
Q1
$23.4K Buy
+482
New +$23.5K 0.01% 294
2023
Q4
Sell
-982
Closed -$52.7K 465
2023
Q3
$52.7K Hold
982
0.01% 221
2023
Q2
$52.9K Hold
982
0.01% 232
2023
Q1
$53.4K Hold
982
0.01% 237
2022
Q4
$47.6K Hold
982
0.01% 245
2022
Q3
$37K Hold
982
0.01% 245
2022
Q2
$49K Hold
982
0.02% 219
2022
Q1
$50K Hold
982
0.01% 234
2021
Q4
$49K Buy
+982
New +$48.6K 0.01% 232
2021
Q2
Sell
-982
Closed -$49K 391
2021
Q1
$49K Buy
+982
New +$47.2K 0.01% 220
2020
Q4
Sell
-785
Closed -$39K 387
2020
Q3
$39K Buy
+785
New +$40.4K 0.01% 216
2019
Q4
Sell
-285
Closed -$13K 442
2019
Q3
$13K Buy
+285
New +$12.3K ﹤0.01% 328
2017
Q4
Sell
-1,197
Closed -$60K 285
2017
Q3
$60K Buy
+1,197
New +$57.9K 0.03% 170

Other funds holding SNY

Northwest Investment Counselors's SNY Position: Q3 2024 in Review

Northwest Investment Counselors opened a new position in Sanofi (SNY) in Q3 2024: 502 shares worth $28.9K. The stake represents 0.01% of the portfolio and ranks #301 among its holdings. This is a return to the name: Northwest Investment Counselors previously reported a position in SNY as recently as Q1 2024.

Northwest Investment Counselors first reported a position in SNY in Q3 2017 and has held it in 14 quarters since. The position peaked at $60K in Q3 2017. 757 funds tracked by Wall St. Rank hold SNY as of Q3 2024.

  • Northwest Investment Counselors held 502 shares of Sanofi worth $28.9K as of Q3 2024.
  • Sanofi was a new Northwest Investment Counselors position in Q3 2024.
  • Sanofi made up 0.01% of Northwest Investment Counselors's portfolio in Q3 2024, its #301 holding.
  • Northwest Investment Counselors first reported a position in Sanofi in Q3 2017 and has held it in 14 quarters since.
  • Northwest Investment Counselors's Sanofi position peaked at $60K in Q3 2017.
  • 757 funds tracked by Wall St. Rank held Sanofi as of Q3 2024.

Based on Northwest Investment Counselors's 13F filing for Q3 2024, filed 21 Oct 2024.